Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein

•Residues 3, 6 and 7 of TcTLE (TLEEFSAKL) peptide are critical for binding affinity.•Amino acids at positions 3, 6 and 7 of TcTLE have limited effect on immunogenicity.•Binding affinity is not the only parameter to evaluate immunogenic peptides. The TcTLE peptide (TLEEFSAKL) is a CD8+ T cell HLA-A*0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2016-04, Vol.78, p.68-76
Hauptverfasser: Lasso, Paola, Cárdenas, Constanza, Guzmán, Fanny, Rosas, Fernando, Thomas, María Carmen, López, Manuel Carlos, González, John Mario, Cuéllar, Adriana, Campanera, Josep Maria, Luque, F. Javier, Puerta, Concepción Judith
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue
container_start_page 68
container_title Peptides (New York, N.Y. : 1980)
container_volume 78
creator Lasso, Paola
Cárdenas, Constanza
Guzmán, Fanny
Rosas, Fernando
Thomas, María Carmen
López, Manuel Carlos
González, John Mario
Cuéllar, Adriana
Campanera, Josep Maria
Luque, F. Javier
Puerta, Concepción Judith
description •Residues 3, 6 and 7 of TcTLE (TLEEFSAKL) peptide are critical for binding affinity.•Amino acids at positions 3, 6 and 7 of TcTLE have limited effect on immunogenicity.•Binding affinity is not the only parameter to evaluate immunogenic peptides. The TcTLE peptide (TLEEFSAKL) is a CD8+ T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein that is efficiently processed, presented and recognized by CD8+ T cells from chagasic patients. Since the immunogenic properties of wild-type epitopes may be enhanced by suitable substitutions in secondary anchor residues, we have studied the effect of introducing specific mutations at position 3, 6 and 7 of the TcTLE peptide. Mutations (E3L, S6V and A7F) were chosen on the basis of in silico predictions and in vitro assays were performed to determine the TcTLE-modified peptide binding capacity to the HLA-A*0201 molecule. In addition, the functional activity of peptide-specific CD8+ T cells in HLA-A2+ chagasic patients was also interrogated. In contrast to bioinformatics predictions, the TcTLE-modified peptide was found to have lower binding affinity and stability than the original peptide. Nevertheless, CD8+ T cells from chronic chagasic patients recognized the TcTLE-modified peptide producing TNF-α and INF-γ and expressing CD107a/b, though in less extension than the response triggered by the original peptide. Overall, although the amino acids at positions 3, 6 and 7 of TcTLE are critical for the peptide affinity, they have a limited effect on the immunogenic properties of the TcTLE epitope.
doi_str_mv 10.1016/j.peptides.2016.02.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1809631848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196978116300183</els_id><sourcerecordid>1776093103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-78569c14b8ba99d23c8b375974dd96772d8327732d2f233bbd28700fe64925f33</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEotPCK1Resknqn8Q_O0ZVoYhBsBjWVmLfUI8mdrCdSuWdeEccpmVbVta1vnvu0b2nqi4Jbggm_OrQzDBnZyE1tNQNpg3G9EW1IVKwuiNcvaw2mCheKyHJWXWe0gFj3LZKvq7OKJddyyTbVL9vxhFMRmFECUzwto8PqPfmLkTUT84H1BtnUVqGlF1esgs-oeBRvgPkpmnx4Qd4Z9AcwwwxO0irVO_R7W5bb3HxVkdIOTqTwaI9MnA8IphdLjiyEN19-R5jmP4q7uPD3PuQwtQjE5dfDn3-8q0mZJXP4Pyb6tXYHxO8fXwvqu8fbvbXt_Xu68dP19tdbRhvcy1kx5Uh7SCHXilLmZEDE50SrbWKC0GtZFQIRi0dKWPDYKkUGI_AW0W7kbGL6t1Jt8z9uRT_enJptd57CEvSRGLFGZGtfB4Vqiyd4u5_UMGxYgSvBvgJNTGkFGHUc3RTuY0mWK8B0Af9FAC9BkBjqksASuPl44xlmMD-a3u6eAHenwAo-7t3EHUyDrwB62IJgrbBPTfjD5YYxYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776093103</pqid></control><display><type>article</type><title>Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lasso, Paola ; Cárdenas, Constanza ; Guzmán, Fanny ; Rosas, Fernando ; Thomas, María Carmen ; López, Manuel Carlos ; González, John Mario ; Cuéllar, Adriana ; Campanera, Josep Maria ; Luque, F. Javier ; Puerta, Concepción Judith</creator><creatorcontrib>Lasso, Paola ; Cárdenas, Constanza ; Guzmán, Fanny ; Rosas, Fernando ; Thomas, María Carmen ; López, Manuel Carlos ; González, John Mario ; Cuéllar, Adriana ; Campanera, Josep Maria ; Luque, F. Javier ; Puerta, Concepción Judith</creatorcontrib><description>•Residues 3, 6 and 7 of TcTLE (TLEEFSAKL) peptide are critical for binding affinity.•Amino acids at positions 3, 6 and 7 of TcTLE have limited effect on immunogenicity.•Binding affinity is not the only parameter to evaluate immunogenic peptides. The TcTLE peptide (TLEEFSAKL) is a CD8+ T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein that is efficiently processed, presented and recognized by CD8+ T cells from chagasic patients. Since the immunogenic properties of wild-type epitopes may be enhanced by suitable substitutions in secondary anchor residues, we have studied the effect of introducing specific mutations at position 3, 6 and 7 of the TcTLE peptide. Mutations (E3L, S6V and A7F) were chosen on the basis of in silico predictions and in vitro assays were performed to determine the TcTLE-modified peptide binding capacity to the HLA-A*0201 molecule. In addition, the functional activity of peptide-specific CD8+ T cells in HLA-A2+ chagasic patients was also interrogated. In contrast to bioinformatics predictions, the TcTLE-modified peptide was found to have lower binding affinity and stability than the original peptide. Nevertheless, CD8+ T cells from chronic chagasic patients recognized the TcTLE-modified peptide producing TNF-α and INF-γ and expressing CD107a/b, though in less extension than the response triggered by the original peptide. Overall, although the amino acids at positions 3, 6 and 7 of TcTLE are critical for the peptide affinity, they have a limited effect on the immunogenic properties of the TcTLE epitope.</description><identifier>ISSN: 0196-9781</identifier><identifier>EISSN: 1873-5169</identifier><identifier>DOI: 10.1016/j.peptides.2016.02.002</identifier><identifier>PMID: 26854383</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Affinity ; Amino Acid Sequence ; Amino Acid Substitution ; Amino acids ; Anchors ; Antibodies, Protozoan - biosynthesis ; Binding ; Binding Sites ; CD8+ T cells ; CD8-Positive T-Lymphocytes - cytology ; CD8-Positive T-Lymphocytes - drug effects ; CD8-Positive T-Lymphocytes - immunology ; Cell Line ; Chagas disease ; Chagas Disease - immunology ; Chagas Disease - parasitology ; Epitopes, T-Lymphocyte - chemistry ; Epitopes, T-Lymphocyte - genetics ; Epitopes, T-Lymphocyte - immunology ; Gene Expression Regulation ; HLA-A2 Antigen - chemistry ; HLA-A2 Antigen - genetics ; HLA-A2 Antigen - immunology ; Humans ; Interferon-gamma - genetics ; Interferon-gamma - immunology ; Lysosomal-Associated Membrane Protein 1 - genetics ; Lysosomal-Associated Membrane Protein 1 - immunology ; Lysosomal-Associated Membrane Protein 2 - genetics ; Lysosomal-Associated Membrane Protein 2 - immunology ; MHC class I ; Mutation ; Mutations ; Patients ; Peptides ; Peptides - chemical synthesis ; Peptides - immunology ; Peptides - pharmacology ; Protein Binding ; Proteins ; Protozoan Proteins - chemistry ; Protozoan Proteins - immunology ; Trypanosoma cruzi ; Trypanosoma cruzi - chemistry ; Trypanosoma cruzi - immunology ; Tumor Necrosis Factor-alpha - genetics ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>Peptides (New York, N.Y. : 1980), 2016-04, Vol.78, p.68-76</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-78569c14b8ba99d23c8b375974dd96772d8327732d2f233bbd28700fe64925f33</citedby><cites>FETCH-LOGICAL-c364t-78569c14b8ba99d23c8b375974dd96772d8327732d2f233bbd28700fe64925f33</cites><orcidid>0000-0002-8049-3567</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.peptides.2016.02.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26854383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lasso, Paola</creatorcontrib><creatorcontrib>Cárdenas, Constanza</creatorcontrib><creatorcontrib>Guzmán, Fanny</creatorcontrib><creatorcontrib>Rosas, Fernando</creatorcontrib><creatorcontrib>Thomas, María Carmen</creatorcontrib><creatorcontrib>López, Manuel Carlos</creatorcontrib><creatorcontrib>González, John Mario</creatorcontrib><creatorcontrib>Cuéllar, Adriana</creatorcontrib><creatorcontrib>Campanera, Josep Maria</creatorcontrib><creatorcontrib>Luque, F. Javier</creatorcontrib><creatorcontrib>Puerta, Concepción Judith</creatorcontrib><title>Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein</title><title>Peptides (New York, N.Y. : 1980)</title><addtitle>Peptides</addtitle><description>•Residues 3, 6 and 7 of TcTLE (TLEEFSAKL) peptide are critical for binding affinity.•Amino acids at positions 3, 6 and 7 of TcTLE have limited effect on immunogenicity.•Binding affinity is not the only parameter to evaluate immunogenic peptides. The TcTLE peptide (TLEEFSAKL) is a CD8+ T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein that is efficiently processed, presented and recognized by CD8+ T cells from chagasic patients. Since the immunogenic properties of wild-type epitopes may be enhanced by suitable substitutions in secondary anchor residues, we have studied the effect of introducing specific mutations at position 3, 6 and 7 of the TcTLE peptide. Mutations (E3L, S6V and A7F) were chosen on the basis of in silico predictions and in vitro assays were performed to determine the TcTLE-modified peptide binding capacity to the HLA-A*0201 molecule. In addition, the functional activity of peptide-specific CD8+ T cells in HLA-A2+ chagasic patients was also interrogated. In contrast to bioinformatics predictions, the TcTLE-modified peptide was found to have lower binding affinity and stability than the original peptide. Nevertheless, CD8+ T cells from chronic chagasic patients recognized the TcTLE-modified peptide producing TNF-α and INF-γ and expressing CD107a/b, though in less extension than the response triggered by the original peptide. Overall, although the amino acids at positions 3, 6 and 7 of TcTLE are critical for the peptide affinity, they have a limited effect on the immunogenic properties of the TcTLE epitope.</description><subject>Affinity</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution</subject><subject>Amino acids</subject><subject>Anchors</subject><subject>Antibodies, Protozoan - biosynthesis</subject><subject>Binding</subject><subject>Binding Sites</subject><subject>CD8+ T cells</subject><subject>CD8-Positive T-Lymphocytes - cytology</subject><subject>CD8-Positive T-Lymphocytes - drug effects</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell Line</subject><subject>Chagas disease</subject><subject>Chagas Disease - immunology</subject><subject>Chagas Disease - parasitology</subject><subject>Epitopes, T-Lymphocyte - chemistry</subject><subject>Epitopes, T-Lymphocyte - genetics</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Gene Expression Regulation</subject><subject>HLA-A2 Antigen - chemistry</subject><subject>HLA-A2 Antigen - genetics</subject><subject>HLA-A2 Antigen - immunology</subject><subject>Humans</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - immunology</subject><subject>Lysosomal-Associated Membrane Protein 1 - genetics</subject><subject>Lysosomal-Associated Membrane Protein 1 - immunology</subject><subject>Lysosomal-Associated Membrane Protein 2 - genetics</subject><subject>Lysosomal-Associated Membrane Protein 2 - immunology</subject><subject>MHC class I</subject><subject>Mutation</subject><subject>Mutations</subject><subject>Patients</subject><subject>Peptides</subject><subject>Peptides - chemical synthesis</subject><subject>Peptides - immunology</subject><subject>Peptides - pharmacology</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>Protozoan Proteins - chemistry</subject><subject>Protozoan Proteins - immunology</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - chemistry</subject><subject>Trypanosoma cruzi - immunology</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>0196-9781</issn><issn>1873-5169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks1u1DAUhSMEotPCK1Resknqn8Q_O0ZVoYhBsBjWVmLfUI8mdrCdSuWdeEccpmVbVta1vnvu0b2nqi4Jbggm_OrQzDBnZyE1tNQNpg3G9EW1IVKwuiNcvaw2mCheKyHJWXWe0gFj3LZKvq7OKJddyyTbVL9vxhFMRmFECUzwto8PqPfmLkTUT84H1BtnUVqGlF1esgs-oeBRvgPkpmnx4Qd4Z9AcwwwxO0irVO_R7W5bb3HxVkdIOTqTwaI9MnA8IphdLjiyEN19-R5jmP4q7uPD3PuQwtQjE5dfDn3-8q0mZJXP4Pyb6tXYHxO8fXwvqu8fbvbXt_Xu68dP19tdbRhvcy1kx5Uh7SCHXilLmZEDE50SrbWKC0GtZFQIRi0dKWPDYKkUGI_AW0W7kbGL6t1Jt8z9uRT_enJptd57CEvSRGLFGZGtfB4Vqiyd4u5_UMGxYgSvBvgJNTGkFGHUc3RTuY0mWK8B0Af9FAC9BkBjqksASuPl44xlmMD-a3u6eAHenwAo-7t3EHUyDrwB62IJgrbBPTfjD5YYxYA</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Lasso, Paola</creator><creator>Cárdenas, Constanza</creator><creator>Guzmán, Fanny</creator><creator>Rosas, Fernando</creator><creator>Thomas, María Carmen</creator><creator>López, Manuel Carlos</creator><creator>González, John Mario</creator><creator>Cuéllar, Adriana</creator><creator>Campanera, Josep Maria</creator><creator>Luque, F. Javier</creator><creator>Puerta, Concepción Judith</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7U5</scope><scope>8FD</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0002-8049-3567</orcidid></search><sort><creationdate>201604</creationdate><title>Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein</title><author>Lasso, Paola ; Cárdenas, Constanza ; Guzmán, Fanny ; Rosas, Fernando ; Thomas, María Carmen ; López, Manuel Carlos ; González, John Mario ; Cuéllar, Adriana ; Campanera, Josep Maria ; Luque, F. Javier ; Puerta, Concepción Judith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-78569c14b8ba99d23c8b375974dd96772d8327732d2f233bbd28700fe64925f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Affinity</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution</topic><topic>Amino acids</topic><topic>Anchors</topic><topic>Antibodies, Protozoan - biosynthesis</topic><topic>Binding</topic><topic>Binding Sites</topic><topic>CD8+ T cells</topic><topic>CD8-Positive T-Lymphocytes - cytology</topic><topic>CD8-Positive T-Lymphocytes - drug effects</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell Line</topic><topic>Chagas disease</topic><topic>Chagas Disease - immunology</topic><topic>Chagas Disease - parasitology</topic><topic>Epitopes, T-Lymphocyte - chemistry</topic><topic>Epitopes, T-Lymphocyte - genetics</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Gene Expression Regulation</topic><topic>HLA-A2 Antigen - chemistry</topic><topic>HLA-A2 Antigen - genetics</topic><topic>HLA-A2 Antigen - immunology</topic><topic>Humans</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - immunology</topic><topic>Lysosomal-Associated Membrane Protein 1 - genetics</topic><topic>Lysosomal-Associated Membrane Protein 1 - immunology</topic><topic>Lysosomal-Associated Membrane Protein 2 - genetics</topic><topic>Lysosomal-Associated Membrane Protein 2 - immunology</topic><topic>MHC class I</topic><topic>Mutation</topic><topic>Mutations</topic><topic>Patients</topic><topic>Peptides</topic><topic>Peptides - chemical synthesis</topic><topic>Peptides - immunology</topic><topic>Peptides - pharmacology</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>Protozoan Proteins - chemistry</topic><topic>Protozoan Proteins - immunology</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - chemistry</topic><topic>Trypanosoma cruzi - immunology</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lasso, Paola</creatorcontrib><creatorcontrib>Cárdenas, Constanza</creatorcontrib><creatorcontrib>Guzmán, Fanny</creatorcontrib><creatorcontrib>Rosas, Fernando</creatorcontrib><creatorcontrib>Thomas, María Carmen</creatorcontrib><creatorcontrib>López, Manuel Carlos</creatorcontrib><creatorcontrib>González, John Mario</creatorcontrib><creatorcontrib>Cuéllar, Adriana</creatorcontrib><creatorcontrib>Campanera, Josep Maria</creatorcontrib><creatorcontrib>Luque, F. Javier</creatorcontrib><creatorcontrib>Puerta, Concepción Judith</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Peptides (New York, N.Y. : 1980)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lasso, Paola</au><au>Cárdenas, Constanza</au><au>Guzmán, Fanny</au><au>Rosas, Fernando</au><au>Thomas, María Carmen</au><au>López, Manuel Carlos</au><au>González, John Mario</au><au>Cuéllar, Adriana</au><au>Campanera, Josep Maria</au><au>Luque, F. Javier</au><au>Puerta, Concepción Judith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein</atitle><jtitle>Peptides (New York, N.Y. : 1980)</jtitle><addtitle>Peptides</addtitle><date>2016-04</date><risdate>2016</risdate><volume>78</volume><spage>68</spage><epage>76</epage><pages>68-76</pages><issn>0196-9781</issn><eissn>1873-5169</eissn><abstract>•Residues 3, 6 and 7 of TcTLE (TLEEFSAKL) peptide are critical for binding affinity.•Amino acids at positions 3, 6 and 7 of TcTLE have limited effect on immunogenicity.•Binding affinity is not the only parameter to evaluate immunogenic peptides. The TcTLE peptide (TLEEFSAKL) is a CD8+ T cell HLA-A*0201-restricted epitope derived from the Trypanosoma cruzi KMP-11 protein that is efficiently processed, presented and recognized by CD8+ T cells from chagasic patients. Since the immunogenic properties of wild-type epitopes may be enhanced by suitable substitutions in secondary anchor residues, we have studied the effect of introducing specific mutations at position 3, 6 and 7 of the TcTLE peptide. Mutations (E3L, S6V and A7F) were chosen on the basis of in silico predictions and in vitro assays were performed to determine the TcTLE-modified peptide binding capacity to the HLA-A*0201 molecule. In addition, the functional activity of peptide-specific CD8+ T cells in HLA-A2+ chagasic patients was also interrogated. In contrast to bioinformatics predictions, the TcTLE-modified peptide was found to have lower binding affinity and stability than the original peptide. Nevertheless, CD8+ T cells from chronic chagasic patients recognized the TcTLE-modified peptide producing TNF-α and INF-γ and expressing CD107a/b, though in less extension than the response triggered by the original peptide. Overall, although the amino acids at positions 3, 6 and 7 of TcTLE are critical for the peptide affinity, they have a limited effect on the immunogenic properties of the TcTLE epitope.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26854383</pmid><doi>10.1016/j.peptides.2016.02.002</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8049-3567</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0196-9781
ispartof Peptides (New York, N.Y. : 1980), 2016-04, Vol.78, p.68-76
issn 0196-9781
1873-5169
language eng
recordid cdi_proquest_miscellaneous_1809631848
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Affinity
Amino Acid Sequence
Amino Acid Substitution
Amino acids
Anchors
Antibodies, Protozoan - biosynthesis
Binding
Binding Sites
CD8+ T cells
CD8-Positive T-Lymphocytes - cytology
CD8-Positive T-Lymphocytes - drug effects
CD8-Positive T-Lymphocytes - immunology
Cell Line
Chagas disease
Chagas Disease - immunology
Chagas Disease - parasitology
Epitopes, T-Lymphocyte - chemistry
Epitopes, T-Lymphocyte - genetics
Epitopes, T-Lymphocyte - immunology
Gene Expression Regulation
HLA-A2 Antigen - chemistry
HLA-A2 Antigen - genetics
HLA-A2 Antigen - immunology
Humans
Interferon-gamma - genetics
Interferon-gamma - immunology
Lysosomal-Associated Membrane Protein 1 - genetics
Lysosomal-Associated Membrane Protein 1 - immunology
Lysosomal-Associated Membrane Protein 2 - genetics
Lysosomal-Associated Membrane Protein 2 - immunology
MHC class I
Mutation
Mutations
Patients
Peptides
Peptides - chemical synthesis
Peptides - immunology
Peptides - pharmacology
Protein Binding
Proteins
Protozoan Proteins - chemistry
Protozoan Proteins - immunology
Trypanosoma cruzi
Trypanosoma cruzi - chemistry
Trypanosoma cruzi - immunology
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - immunology
title Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20secondary%20anchor%20amino%20acid%20substitutions%20on%20the%20immunogenic%20properties%20of%20an%20HLA-A0201-restricted%20T%20cell%20epitope%20derived%20from%20the%20Trypanosoma%20cruzi%20KMP-11%20protein&rft.jtitle=Peptides%20(New%20York,%20N.Y.%20:%201980)&rft.au=Lasso,%20Paola&rft.date=2016-04&rft.volume=78&rft.spage=68&rft.epage=76&rft.pages=68-76&rft.issn=0196-9781&rft.eissn=1873-5169&rft_id=info:doi/10.1016/j.peptides.2016.02.002&rft_dat=%3Cproquest_cross%3E1776093103%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776093103&rft_id=info:pmid/26854383&rft_els_id=S0196978116300183&rfr_iscdi=true